Amyloid beta antibody
This page covers all Amyloid beta antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Amyloid beta.
Targets
Phase 2 pipeline (1)
- BG00010 · Biogen · Neurology
BG00010 is a monoclonal antibody targeting amyloid beta.
Patent intelligence
- amyloid beta antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates